- Inactivation of the p53–KLF8–CEBPA Axis in Acute Myeloid Leukemia
- Inactivation of the p53–KLF9–CEBPA Axis in Acute Myeloid Leukemia
- Inactivation of the p53–KLF10–CEBPA Axis in Acute Myeloid Leukemia
- Plasma gelsolin and matrix metalloproteinase 3 as potential biomarkers for Alzheimer disease
- Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease
- Increased levels of interleukin 31 (IL-31) in osteoporosis
- Trans‐fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll‐like receptors
- Oxytocin receptor: Expression in the trigeminal nociceptive system and potential role in the treatment of headache disorders
- Changes in Bone Metabolism Months after Laparoscopic Morbidly Obese Pre-menopausal Women
- Neuroprotective effect of allicin in a rat model of acute spinal cord injury
- Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease
- The effect of R-(-)-deprenyl administration on reproductive parameters of rat males
- Glycyrrhizin reduces HMGB1 secretion in lipopolysaccharide-activated RAW 264.7 cells and endotoxemic mice by p38/Nrf2-dependent induction of HO-1
- Preconditioning effect of (S)-3, 5-dihydroxyphenylglycine on ischemic injury in middle cerebral artery occluded Sprague–Dawley rats
- PPIA rs6850: A> G single-nucleotide polymorphism is associated with raised plasma cyclophilin A levels in patients with coronary artery disease
- A New Technique for Collection of Cerebrospinal Fluid in Rat Pups
- Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma
- Trypanosoma cruzi infection and benznidazole therapy independently stimulate oxidative status and structural pathological remodeling of the liver tissue in mice
- Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro
- Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
